First published randomized controlled trial for market-leading implant demonstrates impressive outcomes for rotator cuff tears Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, ...
Hosted on MSN
Smith & Nephew’s REGENETEN™ Implant Study: A Potential Game-Changer for Rotator Cuff Treatment
Smith & Nephew Snats ((SNN)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...
Smith+Nephew has completed its acquisition of Integrity Orthopaedics, adding the FDA-cleared Tendon Seam rotator cuff repair system to its shoulder portfolio. The deal supports Smith+Nephew’s RISE ...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces new evidence and market updates that highlight the clinical performance of its REGENETEN Bioinductive Implant ...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces standout results for its REGENETEN Bioinductive Implant from a recently completed randomized controlled trial ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Smith & Nephew is conducting a clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results